Accessibility Menu

Medicenna Therapeutics

(OTC) MDNAF

Current Price$0.31
Market Cap$21.45M
Since IPO (2017)-79%
5 Year-92%
1 Year-57%
1 Month-29%

Medicenna Therapeutics Financials at a Glance

Market Cap

$21.45M

Revenue (TTM)

CA$0.00

Net Income (TTM)

-CA$9.41

EPS (TTM)

-$0.11

P/E Ratio

-2.77

Dividend

$0.00

Beta (Volatility)

0.90 (Low)

Price

$0.31

Volume

41,826

Open

$0.32

Previous Close

$0.31

Daily Range

$0.31 - $0.32

52-Week Range

$0.30 - $1.43

MDNAF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Medicenna Therapeutics

Industry

Biotechnology

Employees

18

CEO

Fahar Merchant, PhD

MDNAF Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-113%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-36.10%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$21.45M

Shares Outstanding

68.74M

Volume

41.83K

Avg. Volume

75.21K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Medicenna Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2020YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

CA$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$21.45M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

-CA$2.35M

N/A

EBITDA

-CA$2.34M

N/A

Quarterly Fundamentals

Name
Q2 2020YOY CHG

Net Cash

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

CA$0.00

N/A

Operating Cash Flow

CA$0.00

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,581.66+0.00%
^DJIDJI
$50,985.51+0.01%
^IXICNASDAQ
$26,978.48+0.00%
BTCBitcoin
$73,775.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$114.68-0.05%
SPCEVirgin Galactic
$6.18+0.36%
ONDSOndas
$13.22-0.00%
NOKNokia
$14.84-0.03%

Questions About MDNAF

What is the current price of Medicenna Therapeutics?

Medicenna Therapeutics is trading at $0.31 per share.

What is the 52-week range for Medicenna Therapeutics?

Over the past 52 weeks, Medicenna Therapeutics has traded between $0.30 and $1.43.

How much debt does Medicenna Therapeutics have?

As of the most recent reporting period, Medicenna Therapeutics reported total debt of CA$98.49K.

How much cash does Medicenna Therapeutics have on hand?

Medicenna Therapeutics reported CA$7.74M in cash and cash equivalents in its most recent financial results.

What is Medicenna Therapeutics’s dividend yield?

Medicenna Therapeutics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.